Saturday, 24 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Deals
BioTroy Therapeutics Secures USD 28M in Series A Funding for CD3L1 Anti-Tumor Drug Development
June 17, 2025
Company
Deals
GlycoT Therapeutics Partners with Innovent Biologics to Advance ADC Technology
June 17, 2025
Company
Deals
Shanghai Escugen and SunRock Biopharma Collaborate on First-in-Class CCR9-Targeted ADC
June 17, 2025
Company
Drug
AbbVie’s Venclexta Fails to Meet Overall Survival Endpoint in HR-MDS Trial
June 17, 2025
Company
Legal / IP
Harbour BioMed Wins CNIPA Validation of ‘Binding Molecule’ Patent Amid Dispute
June 17, 2025
Company
Drug
Roche Advances Prasinezumab to Phase III for Early Parkinson’s Disease
June 17, 2025
Company
Deals
Simcere and NextCure Forge Strategic Alliance to Co-Develop SIM0505 ADC for Solid Tumors
June 17, 2025
Company
AstraZeneca’s Oncology Executive Michael Lai to Leave Company in June
June 24, 2025
Company
Deals
Eli Lilly Close to Acquiring Verve Therapeutics for Up to USD 1.3 Billion
June 17, 2025
Company
Drug
Pediatrix Therapeutics Wins Macau Approval for Neffy Epinephrine Nasal Spray
June 17, 2025
Company
Drug
Minova Pharmaceuticals Launches Rongzhi, China’s First Injectable Adipocytolytic Drug
June 17, 2025
Legal / IP
RemeGen Secures 1,827-Day Patent Extension for Telitacicept in China
June 17, 2025
1
2
…
132
133
134
135
136
…
289
290
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
